Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Delayed Cord Clamping in Very Low Birth Weight Infants
Delayed Cord Clamping at 30 vs. 60 Seconds for Very Low Birth Weight Infants: A Randomized Controlled Trial
Status: Enrolling
Updated:  8/28/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Delayed Cord Clamping in Very Low Birth Weight Infants
Delayed Cord Clamping at 30 vs. 60 Seconds for Very Low Birth Weight Infants: A Randomized Controlled Trial
Status: Enrolling
Updated: 8/28/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Anaheim, CA
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Carmichael, CA
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Carmichael, CA
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Fair Oaks, CA
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Fair Oaks, CA
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Sacramento, CA
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
San Diego, CA
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Boynton Beach, FL
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Indianapolis, IN
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
South Bend, IN
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
South Bend, IN
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Portage, MI
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Portage, MI
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
New York, NY
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Chapel Hill, NC
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Winston-Salem, NC
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Tulsa, OK
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Portland, OR
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Philadelphia, PA
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Memphis, TN
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated:  8/28/2017
GSK Investigational Site
mi
from
Saint Petersburg, FL
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Status: Enrolling
Updated: 8/28/2017
GSK Investigational Site
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Maternal Epidural Steroids and Hyperthemia
Maternal Epidural Steroids to Prevent Neonatal Exposure to Hyperthermia and Inflammation
Status: Enrolling
Updated:  8/28/2017
Medical University of South Carolina
mi
from
Charleston, SC
Maternal Epidural Steroids and Hyperthemia
Maternal Epidural Steroids to Prevent Neonatal Exposure to Hyperthermia and Inflammation
Status: Enrolling
Updated: 8/28/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
INSORB Versus Subcuticular Sutures at Cesarean Section
A Randomized Controlled Trial of Skin Closure at Cesarean Section: INSORB Absorbable Staples Versus Subcuticular Sutures
Status: Enrolling
Updated:  8/29/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
INSORB Versus Subcuticular Sutures at Cesarean Section
A Randomized Controlled Trial of Skin Closure at Cesarean Section: INSORB Absorbable Staples Versus Subcuticular Sutures
Status: Enrolling
Updated: 8/29/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI
Status: Enrolling
Updated:  8/30/2017
Stanford University Hospitals and Clinics
mi
from
Stanford, CA
Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI
Status: Enrolling
Updated: 8/30/2017
Stanford University Hospitals and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin
Randomized Controlled Trial: Cervical Ripening Balloon With and Without Oxytocin for Cervical Ripening in Multiparas
Status: Enrolling
Updated:  8/30/2017
Alison Bauer
mi
from
Cleveland, OH
Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin
Randomized Controlled Trial: Cervical Ripening Balloon With and Without Oxytocin for Cervical Ripening in Multiparas
Status: Enrolling
Updated: 8/30/2017
Alison Bauer
mi
from
Cleveland, OH
Click here to add this to my saved trials
The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair
The Effect of an Additional TVT on OAB Symptoms in Surgical Repair of Pelvic Organ Prolapse
Status: Enrolling
Updated:  8/31/2017
Mount Sinai Hosp
mi
from
New York, NY
The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair
The Effect of an Additional TVT on OAB Symptoms in Surgical Repair of Pelvic Organ Prolapse
Status: Enrolling
Updated: 8/31/2017
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS)
The Effects of Oral Cinnamon Extract on Menstrual Cyclicity in PolyCystic Ovary Syndrome
Status: Enrolling
Updated:  9/5/2017
Columbia University Medical Center
mi
from
New York, NY
Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS)
The Effects of Oral Cinnamon Extract on Menstrual Cyclicity in PolyCystic Ovary Syndrome
Status: Enrolling
Updated: 9/5/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Pilot Study:Role of Dietary Fiber in PCOS Anovulation
Pilot Study: Role of Dietary Fiber in PCOS Anovulation
Status: Enrolling
Updated:  9/8/2017
VCU General Clinical Research Center
mi
from
Richmond, VA
Pilot Study:Role of Dietary Fiber in PCOS Anovulation
Pilot Study: Role of Dietary Fiber in PCOS Anovulation
Status: Enrolling
Updated: 9/8/2017
VCU General Clinical Research Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy
Pilot Study of Intensity Modulated Radiotherapy (IMRT) to Pelvis Post-Hysterectomy With Analysis of Clinical Target Volume Motion and Relation to Position and Volume of Bladder and Rectum During Course of Radiotherapy for Use in Optimization of Margin Size
Status: Enrolling
Updated:  9/11/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy
Pilot Study of Intensity Modulated Radiotherapy (IMRT) to Pelvis Post-Hysterectomy With Analysis of Clinical Target Volume Motion and Relation to Position and Volume of Bladder and Rectum During Course of Radiotherapy for Use in Optimization of Margin Size
Status: Enrolling
Updated: 9/11/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Serum 25(OH)D Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants
Serum 25(OH)D Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants
Status: Enrolling
Updated:  9/13/2017
Nebraska Medical Center
mi
from
Omaha, NE
Serum 25(OH)D Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants
Serum 25(OH)D Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants
Status: Enrolling
Updated: 9/13/2017
Nebraska Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Communication & Peer Support Effects on Physical Activity in Overweight Postmenopausal Women
A Feasibility Study on the Effects of Tailored Communication and Health Coach Support on Physical Activity in Overweight Postmenopausal Women: BePHIT
Status: Enrolling
Updated:  9/13/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Communication & Peer Support Effects on Physical Activity in Overweight Postmenopausal Women
A Feasibility Study on the Effects of Tailored Communication and Health Coach Support on Physical Activity in Overweight Postmenopausal Women: BePHIT
Status: Enrolling
Updated: 9/13/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Positive Airway Pressure in Preeclampsia to Reduce Blood Pressure
Use of PAP in Women With Pre-eclampsia
Status: Enrolling
Updated:  9/14/2017
University of Michigan
mi
from
Ann Arbor, MI
Study of Positive Airway Pressure in Preeclampsia to Reduce Blood Pressure
Use of PAP in Women With Pre-eclampsia
Status: Enrolling
Updated: 9/14/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 14
mi
from
Tucson, AZ
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 14
mi
from
Tucson, AZ
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 21
mi
from
Sacramento, CA
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 21
mi
from
Sacramento, CA
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 17
mi
from
San Diego, CA
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 17
mi
from
San Diego, CA
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 10
mi
from
Meridian, ID
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 10
mi
from
Meridian, ID
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 24
mi
from
Omaha, NE
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 24
mi
from
Omaha, NE
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 19
mi
from
New York, NY
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 19
mi
from
New York, NY
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 16
mi
from
Durham, NC
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 16
mi
from
Durham, NC
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 05
mi
from
Cleveland, OH
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 05
mi
from
Cleveland, OH
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 15
mi
from
Columbus, OH
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 15
mi
from
Columbus, OH
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 09
mi
from
West Jordan, UT
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 09
mi
from
West Jordan, UT
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 39
mi
from
Montgomery, AL
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 39
mi
from
Montgomery, AL
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 36
mi
from
Denver, CO
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 36
mi
from
Denver, CO
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 42
mi
from
Milford, CT
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 42
mi
from
Milford, CT
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 26
mi
from
Jacksonville, FL
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 26
mi
from
Jacksonville, FL
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 80
mi
from
West Palm Beach, FL
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 80
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 23
mi
from
Sandy Springs, GA
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 23
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 27
mi
from
Baltimore, MD
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 27
mi
from
Baltimore, MD
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 22
mi
from
Kalamazoo, MI
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 22
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 25
mi
from
Lincoln, NE
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 25
mi
from
Lincoln, NE
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 28
mi
from
Moorestown, NJ
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 28
mi
from
Moorestown, NJ
Click here to add this to my saved trials
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated:  9/15/2017
EndoCeutics site # 44
mi
from
New Brunswick, NJ
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Status: Enrolling
Updated: 9/15/2017
EndoCeutics site # 44
mi
from
New Brunswick, NJ
Click here to add this to my saved trials